chr6-98874275-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001278716.2(FBXL4):c.*3T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,576,458 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001278716.2 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0163 AC: 2481AN: 152184Hom.: 61 Cov.: 32
GnomAD3 exomes AF: 0.00419 AC: 931AN: 222224Hom.: 18 AF XY: 0.00301 AC XY: 365AN XY: 121226
GnomAD4 exome AF: 0.00154 AC: 2197AN: 1424156Hom.: 55 Cov.: 30 AF XY: 0.00134 AC XY: 948AN XY: 707466
GnomAD4 genome AF: 0.0163 AC: 2486AN: 152302Hom.: 61 Cov.: 32 AF XY: 0.0159 AC XY: 1185AN XY: 74488
ClinVar
Submissions by phenotype
Mitochondrial DNA depletion syndrome 13 Benign:2
The NM_012160.4:c.*3T>C () [GRCH38: NC_000006.12:g.98874275A>G] variant in FBXL4 gene is interpretated to be a Benign - Stand Alone based on ACMG guidelines (PMID: 25741868). This variant meets one or more of the following evidence codes reported in the ACMG-guideline. BA1:Minor allele frequency is too high for the Mitochondrial DNA depletion syndrome 13. BS2:Observation of the variant is in controls is inconsistent with penetrance of Mitochondrial DNA depletion syndrome 13. BP4:Computational evidence/predictors indicate no impact on the FBXL4 structure, function, or protein-protein interaction. Based on this evidence code ClinGen Pathogenicity Calculator (PMID:28081714) suggested that the variant is Benign - Stand Alone. -
- -
not specified Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at